Sudarshan Pharma Industries Stock Screener | Share Price & Fundamental Analysis
SUDARSHAN
Dyes & Pigments
Screen Sudarshan Pharma Industries share price with our stock screener - analyze fundamentals and track trades in your journal
Market Cap
₹669.75 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
4.77
EPS (TTM)
₹0.66
Dividend Yield
-
Debt to Equity
1.13
52W High
-
52W Low
-
Operating Margin
5.00%
Profit Margin
2.34%
Revenue (TTM)
₹171.00
EBITDA
₹11.00
Net Income
₹4.00
Total Assets
₹402.00
Total Equity
₹132.00
Sudarshan Pharma Industries Share Price History - Stock Screener Chart
Screen SUDARSHAN historical share price movements with interactive charts. Analyze price trends and patterns.
Sudarshan Pharma Industries Company Profile - Fundamental Screener
Screen Sudarshan Pharma Industries company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SUDARSHAN shares.
Sector
Chemicals
Industry
Dyes & Pigments
Sub-Sector
Dyes & Pigments
Segment
E
ISIN
INE00TV01023
Sudarshan Pharma Industries Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen SUDARSHAN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 402 | 283 | 233 | 138 | 99 |
| Current Assets | 335 | 237 | 199 | 130 | 88 |
| Fixed Assets | 24 | 26 | 20 | 7 | 6 |
| Liabilities | |||||
| Total Liabilities | 402 | 283 | 233 | 138 | 99 |
| Current Liabilities | 11 | 11 | 13 | 5 | 6 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 132 | 112 | 101 | 30 | 23 |
| Share Capital | 24 | 24 | 24 | 10 | 10 |
| Reserves & Surplus | 104 | 88 | 77 | 20 | 13 |
Screen SUDARSHAN income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar |
|---|---|---|---|---|---|---|---|
| Revenue | 171 | 147 | 162 | 116 | 129 | 100 | 232 |
| Expenses | 160 | 134 | 147 | 108 | 117 | 97 | 217 |
| EBITDA | 11 | 12 | 15 | 9 | 12 | 3 | 15 |
| Operating Profit % | 5.00% | 8.00% | 9.00% | 7.00% | 9.00% | 2.00% | 6.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 6 | 6 | 4 | 4 | 4 | 4 | 6 |
| Profit Before Tax | 4 | 5 | 10 | 4 | 8 | -2 | 9 |
| Tax | 0 | 1 | 3 | 1 | 2 | 0 | 2 |
| Net Profit | 4 | 4 | 7 | 3 | 6 | -1 | 7 |
| EPS | 0.16 | 0.16 | 0.31 | 0.12 | 0.24 | -0.05 | 0.27 |
Sudarshan Pharma Industries Cash Flow Screener - Liquidity Fundamentals
Screen SUDARSHAN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
| Operating Activities | 35 | 8 | -29 | -4 | 3 | 1 |
| Investing Activities | -20 | -7 | -26 | -2 | -1 | -3 |
| Financing Activities | -14 | -12 | 66 | 4 | -2 | 0 |
| Net Cash Flow | 0 | -12 | 12 | -1 | 0 | -2 |
Screen SUDARSHAN shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Sept | 2023-Mar | 2023-Sept |
|---|---|---|---|---|---|---|---|
| Promoter Holding | 57.39% | 57.39% | 57.39% | 57.39% | 57.39% | 57.39% | 57.39% |
| FII Holding | 18.45% | 19.48% | 20.79% | 1.40% | 13.07% | 0.00% | 1.40% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.05% | 0.05% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 18.18% | 17.14% | 16.30% | 23.61% | 23.20% | 20.35% | 27.04% |
| Other Holding | 5.98% | 5.94% | 5.46% | 17.59% | 6.33% | 22.26% | 14.16% |
| Shareholder Count | 1,212 | 1,327 | 1,383 | 913 | 787 | 2,785 | 983 |
Sudarshan Pharma Industries Dividend Screener - Share Yield Analysis
Screen SUDARSHAN dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.30 | 4.05% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
Sudarshan Pharma Industries Index Membership - Market Screener Classification
Screen SUDARSHAN by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Sudarshan Pharma Industries Market Events Screener - Corporate Actions
Screen SUDARSHAN market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Extraordinary General Meeting | NA | 94.52% | ||
| Annual General Meeting | NA | -0.07% | ||
| 2025-10-18 | 2025-10-18 | Quarterly Result Announcement | NA | -2.36% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 0.00% |
| 2025-08-11 | 2025-08-11 | Extraordinary General Meeting | NA | 2.74% |
| 2025-07-25 | 2025-07-25 | Annual General Meeting | NA | -8.80% |
| 2025-06-12 | 2025-06-12 | Extraordinary General Meeting | NA | 4.14% |
| 2025-04-24 | 2025-04-24 | Quarterly Result Announcement | NA | -5.82% |
| 2025-02-04 | 2025-02-04 | Extraordinary General Meeting | NA | -19.06% |
| 2024-11-23 | Split | 1:10 | 0.00% | |
| 2024-10-31 | 2024-10-31 | Quarterly Result Announcement | NA | 9.01% |
| 2024-02-05 | 2024-02-05 | Extraordinary General Meeting | NA | 2.39% |
| 2023-08-25 | 2023-08-26 | Dividend | ₹ 0.30 /share | 20.74% |
Sudarshan Pharma Industries Competitors Screener - Peer Comparison
Screen SUDARSHAN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sudarshan Chemical Industries | 7,326 | 97.91 | 3,379 | 32.20% | 60 | 30.80 |
| Kiri Industries | 3,681 | 30.07 | 855 | 14.72% | 265 | 64.11 |
| Indokem | 1,664 | 309.38 | 179 | 8.23% | 3 | 24.49 |
| Ultramarine & Pigments | 1,220 | 15.51 | 707 | 23.84% | 75 | 44.04 |
| Shree Pushkar Chemicals | 1,218 | 16.96 | 817 | 10.88% | 59 | 44.17 |
| Heubach Colorants | 1,093 | 17.95 | 844 | 5.55% | 51 | 53.88 |
| Bhageria Industries | 787 | 16.09 | 602 | 17.68% | 39 | 45.33 |
| Sudarshan Pharma Industries | 670 | 36.96 | 508 | 8.90% | 16 | 61.65 |
| Bodal Chemicals | 668 | 19.19 | 1,757 | 23.76% | 19 | 45.09 |
| Vipul Organics | 404 | 75.43 | 163 | 8.01% | 4 | 61.21 |
Sudarshan Pharma Industries Company Announcements - News Screener
Screen SUDARSHAN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-07 | Closure of Trading Window | View |
| 2025-12-17 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | View |
| 2025-12-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-12-11 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-12-02 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-10-20 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-20 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-19 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |
| 2025-10-18 | Financial Results For The Quarter And Half Year Ended 30-Sep-2025 | View |
| 2025-10-15 | Board Meeting Intimation for Approval Of Financial Results For The Quarter And Half Year Ended 30-Sep-2025 | View |
| 2025-09-30 | Closure of Trading Window | View |
| 2025-09-08 | Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-09-08 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | View |
| 2025-08-18 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-08-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-14 | Announcement under Regulation 30 (LODR)-Acquisition | View |
| 2025-08-14 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-08-14 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-08-14 | Financial Results For The Quarter 30-06-2025 | View |
| 2025-08-12 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |